Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

23rd Annual Needham Virtual Healthcare ConferenceFireside Chat: Tuesday, April 9, 2024 at 3:45 pm ET Location: Virtual

Chardan's 8th Annual Genetic Medicines + Cell Therapy Manufacturing SummitFireside Chat: Monday, April 29, 2024 at 9:30 am ET Location: Virtual

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & InvestorsSarah Spencer +1 857-242-6076[email protected]

You May Also Be Interested In

• XPPen Debuts Magic Pro 13 at IFA 2026, a Professional All-Scenario Drawing Pad Built to Empower Mobile Creative Workflow
• RCI Banque: ‘’Consolidated Financial Statements as at June 30th 2026’’ is now available’’
• RCI Banque : ‘’ Financial Report as at June 30th 2026’’